• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
CXSS2400125 派安普利单抗注射液 penpulimab Injection Biological Products(2.2) New Drug Application 2024-11-21 view
CXSS2300089 派安普利单抗注射液 penpulimab Injection Biological Products(2.2) New Drug Application 2023-12-02 view
CYSB2300137 派安普利单抗注射液 penpulimab Injection Biological Products(1) Supplementary Application 2023-07-18 view
CXSB2300054 派安普利单抗注射液 penpulimab Injection Biological Products Supplementary Application 2023-05-22 view
CXSL2300146 派安普利单抗注射液 penpulimab Injection Biological Products(2.2) New Drug Application 2023-02-22 Zhengda Tianqing Kangfang (Shanghai) Biomedical Technology Co Ltd view
CYSB2300043 派安普利单抗注射液 penpulimab Injection Biological Products(1) Supplementary Application 2023-02-17 view
CYSB2200192 派安普利单抗注射液 penpulimab Injection Biological Products(1) Supplementary Application 2022-08-11 view
CXSL2200283 派安普利单抗注射液 penpulimab Injection Biological Products(2.2) New Drug Application 2022-06-20 Zhengda Tianqing Kangfang (Shanghai) Biomedical Technology Co Ltd view
CYSB2101281 派安普利单抗注射液 penpulimab Injection Biological Products(1) Supplementary Application 2021-12-08 view
CXSS2101020 派安普利单抗注射液 penpulimab Injection Biological Products(1) New Drug Application 2021-08-05 view
CXSS2101007 派安普利单抗注射液 penpulimab Injection Biological Products(1) New Drug Application 2021-07-13 view
CXSL2101056 派安普利单抗注射液 penpulimab Injection Biological Products(1) New Drug Application 2021-05-08 Zhengda Tianqing Kangfang (Shanghai) Biomedical Technology Co Ltd view
CXSS2000022 派安普利单抗注射液 penpulimab Injection Biological Products(1) New Drug Application 2020-05-28 中山康方生物医药有限公司,正大天晴康方(上海)生物医药科技有限公司 Certificate Issued 2021-08-10 view